Section Arrow
ASRT.NASDAQ
- Assertio Holdings
Quotes are at least 15-min delayed:2024/06/04 15:18 EDT
Last
 0.96
-0.04 (-4.00%)
Day High 
0.9947 
Prev. Close
1-M High
1.255 
Volume 
270.21K 
Bid
0.96
Ask
0.9712
Day Low
0.96 
Open
0.99 
1-M Low
0.9201 
Market Cap 
95.12M 
Currency USD 
P/E -- 
%Yield
10-SMA
20-SMA 1.03 
50-SMA 0.95 
52-W High 6.41 
52-W Low 0.7324 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.65/0.16
Enterprise Value
134.80M
Balance Sheet
Book Value Per Share
1.41
Cash Flow
Cash Flow Yield
0.42
Income Statement
Total Revenue
152.07M
Operating Revenue Per Share
1.77
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.775-0.02-1.11%-- 
ESPREsperion Therapeutics2.26+0.02+0.89%-- 
TEVATeva Pharmaceutical Industries Limited16.655-0.325-1.91%-- 
CGCCanopy Growth Corp7.75-0.27-3.37%-- 
HLNHaleon plc8.39-0.08-0.94%28.27PE
Quotes are at least 15-min delayed:2024/06/04 15:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.